Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Vonderhaar Website

Barbara K. Vonderhaar, Ph.D.

Selected Publications

1)  Raafat A, Goldhar AS, Klauzinska M, Xu K, Amirjazil I, McCurdy D, Lashin K, Salomon D, Vonderhaar BK, Egan S, Callahan R.
Expression of Notch receptors, ligands, and target genes during development of the mouse mammary gland.
J. Cell. Physiol. 226: 1940-52, 2011.
[Journal]
2)  Nyante SJ, Faupel-Badger JM, Sherman ME, Pfeiffer RM, Gaudet MM, Falk RT, Andaya AA, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Chanock S, Garcia-Closas M, Figueroa JD.
Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.
Breast cancer research : BCR. 13: R42, 2011.
[Journal]
3)  Goldhar AS, Duan R, Ginsburg E, Vonderhaar BK.
Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP.
Mol. Cell. Endocrinol. 335: 148-57, 2011.
[Journal]
4)  Faupel-Badger JM, Ginsburg E, Fleming JM, Susser L, Doucet T, Vonderhaar BK.
16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo.
Horm Cancer. 1: 71-79, 2010.
[Journal]
5)  Meyer MJ, Fleming JM, Lin AF, Hussnain SA, Ginsburg E, Vonderhaar BK.
CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer.
Cancer Res. 70: 4624-33, 2010.
[Journal]
6)  Ginsburg E, Alexander S, Lieber S, Tarplin S, Jenkins L, Pang L, Heger CD, Goldsmith P, Vonderhaar BK.
Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies.
BMC Cancer. 10: 678, 2010.
[Journal]
7)  Watanabe K, Meyer MJ, Strizzi L, Lee JM, Gonzales M, Bianco C, Nagaoka T, Farid SS, Margaryan N, Hendrix MJ, Vonderhaar BK, Salomon DS.
Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells.
Stem Cells. 28: 1303-14, 2010.
[Journal]
8)  Raafat A, Goldhar AS, Klauzinska M, Xu K, Amirjaz I, McCurdy D, Lashin K, Salomon D, Vonderhaar BK, Egan S, Callahan R.
Expression of Notch receptors, ligands and target genes during development of the mouse mammary gland.
J. Cell. Physiol. 2010.
[Journal]
9)  Fleming JM, Miller TC, Meyer MJ, Ginsburg E, Vonderhaar BK.
Local regulation of human breast xenograft models.
J. Cell. Physiol. 224: 795-806, 2010.
[Journal]
10)  Faupel-Badger JM, Sherman ME, Garcia-Closas M, Gaudet MM, Falk RT, Andaya A, Pfeiffer RM, Yang XR, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Figueroa JD.
Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland.
Br. J. Cancer. 103: 1097-102, 2010.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 5/19/2011.